Study protocol on Alzheimer’s disease and related disorders: focus on clinical and imaging predictive markers in co-existing lesions

被引：0

作者：

Nawele Boublay

Denis Fédérico

Alain Pesce

Marc Verny

Frédéric Blanc

Marc Paccalin

Thomas Desmidt

Pierre Grosmaître

Olivier Moreaud

Solveig Relland

Estelle Bravant

Romain Bouet

Pierre Krolak-Salmon

机构：

[1] Clinical and Research Memory Centre of Lyon,Département de gérontologie clinique et centre mémoire

[2] Hospital of Charpennes,Geriatrics day hospital. Geriatrics department, Memory Resources and Research Centre (CMRR)

[3] Hospices Civils de Lyon,Team IMIS/Neurocrypto, French National Center for Scientific Research (CNRS), ICube Laboratory and Fédération de Médecine Translationnelle de Strasbourg (FMTS)

[4] INSERM,Pôle de Gériatrie CHU Poitiers 86000 Poitiers, 3INSERM, CHU de Poitiers

[5] U1028; CNRS,undefined

[6] UMR5292; Lyon Neuroscience Research Center,undefined

[7] Brain Dynamics and Cognition Team,undefined

[8] Clinical Research Centre (Vieillissement – Cerveau - Fragilité),undefined

[9] Hospital of Charpennes,undefined

[10] Hospices Civils de Lyon,undefined

[11] University Lyon,undefined

[12] Hospices Civils de Lyon,undefined

[13] Pôle Information Médicale Evaluation Recherche,undefined

[14] Centre Rainier III,undefined

[15] Clinical and Research Memory Centre and Geriatrics department of Ile de France Sud,undefined

[16] Hôpital Pitié-Salpêtrière,undefined

[17] AP-HP,undefined

[18] University Pierre et Marie Curie et DHU FAST,undefined

[19] UMR 8256 (CNRS),undefined

[20] University Hospital of Strasbourg,undefined

[21] University of Strasbourg,undefined

[22] Clinical and Research Memory Centre of Poitiers,undefined

[23] CHU Poitiers,undefined

[24] Université de Poitiers,undefined

[25] centre d’investigation clinique CIC1402,undefined

[26] Clinical and Research Memory Centre of Tours,undefined

[27] CHRU Tours,undefined

[28] Clinical and Research Memory Centre of Lyon,undefined

[29] Hospital of Dugoujon,undefined

[30] Hospices Civils de Lyon,undefined

[31] Clinical and Research Memory Centre of Grenoble Arc Alpin,undefined

[32] Pôle de psychiatrie et neurologie,undefined

[33] CHU de Grenoble,undefined

[34] Laboratoire de psychologie et neurocognition,undefined

[35] CNRS UMR 5105,undefined

[36] Hospices civils de Lyon,undefined

[37] hôpital des Charpennes,undefined

来源：

BMC Geriatrics | / 18卷

关键词：

Co-lesions; Alzheimer’s disease; Lewy body dementia; Cerebrovascular disease; Imaging; Predictive markers;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Alzheimer's disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial
Callahan, Christopher M.
Boustani, Malaz A.
Schmid, Arlene A.
Austrom, Mary G.
Miller, Douglas K.
Gao, Sujuan
Morris, Carrie S.
Vogel, Mickey
Hendrie, Hugh C.
TRIALS, 2012, 13
[42] The phenotypical core of Alzheimer's disease-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study
Di Stefano, Francesca
Kas, Aurelie
Habert, Marie-Odile
Decazes, Pierre
Lamari, Foudil
Lista, Simone
Hampel, Harald
Teichmann, Marc
ALZHEIMERS & DEMENTIA, 2016, 12 (07) : 786 - 795
[43] Shared Latent Structures Between Imaging Features and Biomarkers in Early Stages of Alzheimer's Disease: A Predictive Study
Casamitjana, Adria
Petrone, Paula
Luis Molinuevo, Jose
Domingo Gispert, Juan
Vilaplana, Veronica
IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2020, 24 (02) : 365 - 376
[44] Neuroimaging markers of global cognition in early Alzheimer's disease: A magnetic resonance imaging-electroencephalography study
Waser, Markus
Benke, Thomas
Dal-Bianco, Peter
Garn, Heinrich
Mosbacher, Jochen A.
Ransmayr, Gerhard
Schmidt, Reinhold
Seiler, Stephan
Sorensen, Helge B. D.
Jennum, Poul J.
BRAIN AND BEHAVIOR, 2019, 9 (01):
[45] BDNF and markers of disease progression in Alzheimer's disease: Findings from the Australian Imaging Biomarkers & Lifestyle Flagship Study of Ageing
Maruff, P.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 33 - 33
[46] Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: Multicenter study in Japan
Nishimura, T
Takeda, M
Nakamura, Y
Yosbida, Y
Arai, H
Sasaki, H
Shouji, M
Hirai, S
Khise, K
Tanaka, K
Hamamoto, M
Yamamoto, H
Matsubayashi, T
Urakami, K
Adachi, Y
Nakashima, K
Toji, H
Nakamura, S
Yoshida, H
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1998, 20 (03): : 227 - 235
[47] Analysis of clinical and imaging features of Behcet's disease-related pulmonary lesions: a series of eight cases
Zhang, Bingjie
Yang, Yuanhua
Kuang, Tuguang
Xu, Zhuozai
Gong, Juanni
CHINESE MEDICAL JOURNAL, 2022, 135 (16) : 2011 - 2013
[48] Analysis of clinical and imaging features of Behcet’s disease-related pulmonary lesions: a series of eight cases
Zhang Bingjie
Yang Yuanhua
Kuang Tuguang
Xu Zhuozai
Gong Juanni
中华医学杂志英文版, 2022, 135 (16) : 2011 - 2013
[49] The clinical diagnosis of Alzheimer's disease without the use of head imaging studies. A cliniconeuropathological study
Ala, Thomas A.
Mattson, Michael D.
Frey, William H., II
JOURNAL OF ALZHEIMERS DISEASE, 2003, 5 (06) : 463 - 465
[50] Neuroimaging heats up - New study hopes to validate imaging tools and markers for tracking Alzheimer's disease.
Ratner, M
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (08) : 616 - 617

← 1 2 3 4 5 →